GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Millennium Pharmacon International Tbk (ISX:SDPC) » Definitions » Equity-to-Asset

PT Millennium Pharmacon International Tbk (ISX:SDPC) Equity-to-Asset : 0.17 (As of Sep. 2024)


View and export this data going back to 1990. Start your Free Trial

What is PT Millennium Pharmacon International Tbk Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. PT Millennium Pharmacon International Tbk's Total Stockholders Equity for the quarter that ended in Sep. 2024 was Rp295,048 Mil. PT Millennium Pharmacon International Tbk's Total Assets for the quarter that ended in Sep. 2024 was Rp1,783,742 Mil. Therefore, PT Millennium Pharmacon International Tbk's Equity to Asset Ratio for the quarter that ended in Sep. 2024 was 0.17.

The historical rank and industry rank for PT Millennium Pharmacon International Tbk's Equity-to-Asset or its related term are showing as below:

ISX:SDPC' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.15   Med: 0.19   Max: 0.24
Current: 0.17

During the past 13 years, the highest Equity to Asset Ratio of PT Millennium Pharmacon International Tbk was 0.24. The lowest was 0.15. And the median was 0.19.

ISX:SDPC's Equity-to-Asset is ranked worse than
86.36% of 110 companies
in the Medical Distribution industry
Industry Median: 0.405 vs ISX:SDPC: 0.17

PT Millennium Pharmacon International Tbk Equity-to-Asset Historical Data

The historical data trend for PT Millennium Pharmacon International Tbk's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Millennium Pharmacon International Tbk Equity-to-Asset Chart

PT Millennium Pharmacon International Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.19 0.20 0.20 0.19 0.17

PT Millennium Pharmacon International Tbk Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.17 0.15 0.16 0.17

Competitive Comparison of PT Millennium Pharmacon International Tbk's Equity-to-Asset

For the Medical Distribution subindustry, PT Millennium Pharmacon International Tbk's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Millennium Pharmacon International Tbk's Equity-to-Asset Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Millennium Pharmacon International Tbk's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where PT Millennium Pharmacon International Tbk's Equity-to-Asset falls into.



PT Millennium Pharmacon International Tbk Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

PT Millennium Pharmacon International Tbk's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=277717.214/1639682.292
=0.17

PT Millennium Pharmacon International Tbk's Equity to Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

Equity to Asset (Q: Sep. 2024 )=Total Stockholders Equity/Total Assets
=295048.355/1783742.47
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Millennium Pharmacon International Tbk  (ISX:SDPC) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


PT Millennium Pharmacon International Tbk Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of PT Millennium Pharmacon International Tbk's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Millennium Pharmacon International Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan.Sultan Iskandar Muda No 18, Crown Bungur Arteri Lantai 2-4th Floors, Jakarta, IDN, 12240
PT Millennium Pharmacon International Tbk is engaged in distributing medicines, food supplements, and medical disposables. The operating segments of the group are Prescription medicine, Non-prescription medicine, and Medical devices, of which the majority of the revenue is derived from the Prescription Medicine segment.. The company's geographical segments are Java, Sumatera, Kalimantan, Sulawesi, and Bali.

PT Millennium Pharmacon International Tbk Headlines

No Headlines